Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma
- 1 December 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (5) , 1256-1263
- https://doi.org/10.1016/s0360-3016(01)01733-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Integrating radiation therapy in the curative management of ovarian cancer: Current issues and future directionsSeminars in Radiation Oncology, 2000
- Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II TrialGynecologic Oncology, 1998
- Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary ReportGynecologic Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Ovarian CancerJAMA, 1995
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Oral etoposide is active against platinum-resistant epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- Second‐line chemotherapy for recurrent carcinoma of the ovaryCancer, 1993
- Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancerGynecologic Oncology, 1992
- Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinomaGynecologic Oncology, 1989